US Patent 10138487 Aptamers against glioma cells
Patent 10138487 was granted and assigned to University of Central Lancashire on November, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+439 characters)
Article
Patent abstract
Provided are aptamers able to bind to ligands associated with cancer cells. The ligands may particularly be associated with brain cancers, such as gliomas. The aptamers may be used therapeutically for the prevention and/or treatment of such cancers. Aptamers may be associated with anti-cancer agents, or with detection moieties. Also provided as pharmaceutical compositions and methods of treatment employing such aptamers.
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Clare Lawrence0
Jane Adler0
Lisa Shaw0
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
101384870
Date of Patent
November 27, 2018
0Patent Application Number
158019280
Date Filed
November 2, 2017
0Patent Citations Received
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Edits on 9 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 23 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10138487 Aptamers against glioma cells
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10138487
Date of patent
November 27, 2018
Patent application number
15801928
Date Filed
November 2, 2017
Patent primary examiner
Find more entities like US Patent 10138487 Aptamers against glioma cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.